These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9289778)

  • 21. The efficacy and safety of fluvastatin in hypercholesterolemia in renal transplant recipients.
    Ghods AJ; Milanian I; Arghani H; Ghadiri G
    Transplant Proc; 1995 Oct; 27(5):2579-80. PubMed ID: 7482835
    [No Abstract]   [Full Text] [Related]  

  • 22. Fluvastatin titrate-to-goal clinical practice study.
    Weiss RJ
    Am J Ther; 1998 Sep; 5(5):281-5. PubMed ID: 10099070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of fluvastatin, a new inhibitor of HMG-CoA reductase, and niceritrol on serum lipids, lipoproteins and cholesterol ester transfer activity in primary hypercholesterolemic patients.
    Sasaki J; Yamamoto K; Kobori S; Setoguchi Y; Sato Y; Matsunaga A; Shichiri M; Sakai T; Kono S; Arakawa K
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):420-6. PubMed ID: 7582401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fluvastatin in a comparative study. Are there substance-specific differences between various CSE-inhibitors?].
    Internist (Berl); 1999 Mar; 40(3 Suppl Gibt Es):1-4. PubMed ID: 10192028
    [No Abstract]   [Full Text] [Related]  

  • 25. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
    van der Linde NA; Sijbrands EJ; Boomsma F; van den Meiracker AH
    Hypertension; 2006 Jun; 47(6):1125-30. PubMed ID: 16618834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of long acting fluvastatin on parameters of lipid metabolism in patients with type 2 diabetes and combined hyperlipidemia].
    Kozlov SG; Liakishev AA; Titov VN; Naumov VG
    Kardiologiia; 2004; 44(10):60-3. PubMed ID: 15477793
    [No Abstract]   [Full Text] [Related]  

  • 28. [Fluvastatin].
    Teramoto T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():587-91. PubMed ID: 11347136
    [No Abstract]   [Full Text] [Related]  

  • 29. Fluvastatin in renal transplantation.
    Hadjigavriel M; Kyriakides G
    Transplant Proc; 1997 Nov; 29(7):3050. PubMed ID: 9365661
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
    Leu HB; Chen JW; Wu TC; Ding YA; Lin SJ; Charng MJ
    Clin Cardiol; 2005 Sep; 28(9):423-8. PubMed ID: 16250265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
    Mendoza S; Gamez R; Mas R; Goicochea E
    Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluvastatin: what is the evidence?
    Bagg W; Braatvedt G
    N Z Med J; 1997 Aug; 110(1050):321-2. PubMed ID: 9315035
    [No Abstract]   [Full Text] [Related]  

  • 33. Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses.
    Rindone JP; Arriola G; Hiller D; Achacoso R
    Am J Cardiol; 1997 Aug; 80(3):348-9. PubMed ID: 9264434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of statins on circulating oxidized low-density lipoprotein in patients with hypercholesterolemia.
    Inami S; Okamatsu K; Takano M; Takagi G; Sakai S; Sano J; Mizuno K
    Jpn Heart J; 2004 Nov; 45(6):969-75. PubMed ID: 15655272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxymethylglutaryl coenzyme a reductase inhibition: fluvastatin, a clinical investigators' update. Introduction.
    Brown WV
    Am J Cardiol; 1994 May; 73(14):1D-2D. PubMed ID: 8198017
    [No Abstract]   [Full Text] [Related]  

  • 36. Lipid-lowering effects of fluvastatin in renal transplant patients. A clinical observation.
    Lal SM; Gupta N; Georgiev O; Ross G
    Int J Artif Organs; 1997 Jan; 20(1):18-21. PubMed ID: 9062827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
    Liem AH; van Boven AJ; Veeger NJ; Withagen AJ; Robles de Medina RM; Tijssen JG; van Veldhuisen DJ;
    Int J Cardiol; 2004 Feb; 93(2-3):175-9. PubMed ID: 14975544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics.
    Fauler G; Abletshauser C; Erwa W; Löser R; Witschital K; März W
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):328-34. PubMed ID: 17595890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of hypercholesterolemia with fluvastatin in kidney transplant patients.
    Melchor JL; Gracida C
    Transplant Proc; 1998 Aug; 30(5):2054. PubMed ID: 9723390
    [No Abstract]   [Full Text] [Related]  

  • 40. [An update on the use of fluvastatin in primary hypercholesterolemia].
    Baggio G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():43S. PubMed ID: 8562264
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.